We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $1.01B
1-Year Est. Return 29.84%
This Fund
S&P 500
This Quarter Est. Return
-5.28%
1 Year Est. Return
+29.84%
3 Year Est. Return
+144%
5 Year Est. Return
+76.57%
10 Year Est. Return
+1,417.6%
AUM
$2.16B
AUM Growth
-$686M
Cap. Flow
-$227M
Cap. Flow %
-10.51%
Top 10 Hldgs %
54.85%
Holding
104
New
19
Increased
23
Reduced
7
Closed
33

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$34.9M
2
BAC icon
Bank of America
BAC
+$19.3M
3
CFG icon
Citizens Financial Group
CFG
+$18.4M
4
AMZN icon
Amazon
AMZN
+$17.6M
5
MA icon
Mastercard
MA
+$15.2M

Top Sells

Rank Stock Value
1
PCYC
PHARMACYCLICS INC
PCYC
+$27.5M
2
DG icon
Dollar General
DG
+$14.1M
3
OXY icon
Occidental Petroleum
OXY
+$12.1M
4
ARMK icon
Aramark
ARMK
+$9.35M
5
TWX
Time Warner Inc
TWX
+$8.54M

Sector Composition

Rank Sector Weight
1 Healthcare 32.7%
2 Consumer Discretionary 15.06%
3 Financials 5.94%
4 Communication Services 4.21%
5 Technology 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LXRX icon
1
Lexicon Pharmaceuticals
LXRX
$1.02B
$378M 17.5%
57,517,981
– –
WW
2
DELISTED
WW International
WW
$206M 9.51%
29,443,300
– –
SPY icon
3
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$776B
$103M 4.77%
500,000
-900,000
-64% -$186M
BIIB icon
4
CALL
Biogen
BIIB
$31.8B
$99.2M 4.59%
235,000
+63,000
+37% +$24.8M
MRK icon
5
CALL
Merck
MRK
$323B
$97.7M 4.52%
1,781,600
-104,800
-6% -$5.93M
BAC icon
6
CALL
Bank of America
BAC
$434B
$77M 3.56%
5,000,000
+2,600,000
+108% +$41.8M
BMRN icon
7
BioMarin Pharmaceuticals
BMRN
$12B
$59.8M 2.77%
480,000
– –
MET icon
8
CALL
MetLife
MET
$62.7B
$55.6M 2.57%
1,234,200
+673,200
+120% +$30.3M
YUM icon
9
CALL
Yum! Brands
YUM
$42.3B
$55.1M 2.55%
973,700
– –
JPM icon
10
CALL
JPMorgan Chase
JPM
$930B
$54.5M 2.52%
900,000
– –
GOOG icon
11
Alphabet (Google) Class C
GOOG
$4.06T
$49.3M 2.28%
1,804,942
+1,303,569
+260% +$34.9M
ALNY icon
12
Alnylam Pharmaceuticals
ALNY
$38.5B
$49.1M 2.27%
470,000
+70,000
+18% +$7.09M
BABA icon
13
Alibaba
BABA
$274B
$47.9M 2.21%
575,000
+100,000
+21% +$9.02M
INCY icon
14
Incyte
INCY
$25.5B
$46.7M 2.16%
510,000
+100,000
+24% +$8.27M
BLUE
15
DELISTED
bluebird bio
BLUE
$42.3M 1.95%
27,020
+5,790
+27% +$7.64M
MCD icon
16
CALL
McDonald's
MCD
$194B
$39M 1.8%
400,000
-300,000
-43% -$28.5M
TEVA icon
17
CALL
Teva Pharmaceuticals
TEVA
$40.2B
$37.4M 1.73%
600,000
+100,000
+20% +$5.81M
CELG
18
CALL
DELISTED
Celgene Corp
CELG
$34.6M 1.6%
+300,000
New +$35.8M
MA icon
19
Mastercard
MA
$498B
$30.2M 1.4%
350,000
+175,000
+100% +$15.2M
LNKD
20
DELISTED
LinkedIn Corporation
LNKD
$27.5M 1.27%
110,000
+50,000
+83% +$12.4M
ARRY
21
DELISTED
Array Biopharma Inc
ARRY
$27.3M 1.26%
3,710,000
+710,000
+24% +$5.05M
IONS icon
22
Ionis Pharmaceuticals
IONS
$9.13B
$25.5M 1.18%
400,000
-5,000
-1% -$339K
BMRN icon
23
CALL
BioMarin Pharmaceuticals
BMRN
$12B
$24.9M 1.15%
200,000
-100,000
-33% -$10.6M
GE icon
24
CALL
GE Aerospace
GE
$368B
$24.8M 1.15%
208,662
– –
WMT icon
25
CALL
Walmart Inc
WMT
$905B
$24.7M 1.14%
+900,000
New +$25.5M
1
2 3 4 5

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Artal Group's Q1 2015 Portfolio in Review

As of Q1 2015, Artal Group held 104 positions worth $2.16B, down 24% from $2.85B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Artal Group withdrew a net $227M in Q1 2015, closing 33 positions and reducing 7 holdings. Its most notable exit was PHARMACYCLICS INC, an estimated $27.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Artal Group opened a new position in Bank of America worth $18.5M.

  • Artal Group's largest Q1 2015 buy was Bank of America: 1,200,000 shares worth $18.5M.
  • Artal Group added most to Alphabet (Google) Class C in Q1 2015, an estimated $34.9M increase.
  • Artal Group's biggest Q1 2015 reduction was Aptiv, cutting an estimated $1.88M.
  • Artal Group fully exited PHARMACYCLICS INC in Q1 2015, selling an estimated $27.5M.
  • Artal Group's ten largest holdings make up 55% of its $2.16B portfolio in Q1 2015.
  • Artal Group opened 19 new positions and closed 33 in Q1 2015.
  • Artal Group's portfolio value fell 24% quarter-over-quarter to $2.16B.

Based on Artal Group's 13F filing for Q1 2015, filed 13 May 2015.